CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Tubulinopathies continued: refining the phenotypic spectrum associated with variants in TUBG1.
|
29706637 |
2018 |
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Analysis of 17 genes detects mutations in 81% of 811 patients with lissencephaly.
|
29671837 |
2018 |
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly.
|
23603762 |
2013 |
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Cortical Dysplasia
|
0.400 |
Biomarker
|
disease |
CTD_human |
Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly.
|
23603762 |
2013 |
Cortical Dysplasia
|
0.400 |
Biomarker
|
disease |
HPO |
|
|
|
Malformations of Cortical Development
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
De novo heterozygous missense variants in the γ-tubulin gene TUBG1 have been linked to human malformations of cortical development associated with intellectual disability and epilepsy.
|
31086189 |
2019 |
Malformations of Cortical Development
|
0.320 |
Biomarker
|
disease |
BEFREE |
Inputs from genetic studies were provided through the identification of several mutated genes encoding either proteins associated with microtubules (DCX, LIS1, KIF2A, KIF5C, DYNC1H1) or tubulin subunits (TUBA1A, TUBB2B, TUBB5 and TUBG1), in malformations of cortical development (MCD).
|
24179174 |
2014 |
Malformations of Cortical Development
|
0.320 |
Biomarker
|
disease |
CTD_human |
Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly.
|
23603762 |
2013 |
Microcephaly
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Variants in TUBG1 have been described in three patients with posterior predominant pachygyria and microcephaly.
|
29706637 |
2018 |
Microlissencephaly
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
The core phenotype of TUBA1A and TUBG1 tubulinopathies are lissencephalies and microlissencephalies, whereas TUBB2B tubulinopathies show in the majority, centrally predominant polymicrogyria-like cortical dysplasia.
|
24860126 |
2014 |
Microcephaly
|
0.310 |
Biomarker
|
disease |
CTD_human |
Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly.
|
23603762 |
2013 |
Microlissencephaly
|
0.310 |
Biomarker
|
disease |
CTD_human |
Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly.
|
23603762 |
2013 |
Severe Congenital Microcephaly
|
0.300 |
Biomarker
|
disease |
CTD_human |
Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly.
|
23603762 |
2013 |
Pachygyria
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Variants in TUBG1 have been described in three patients with posterior predominant pachygyria and microcephaly.
|
29706637 |
2018 |
Pachygyria
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Seizures
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Global developmental delay
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Subcortical Band Heterotopia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Variable expressivity
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Agyria
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Malignant neoplasm of breast
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Following on these observations, we further assessed the link between the AURKA-HMMR-TPX2-TUBG1 functional module and risk of breast cancer in BRCA1 or BRCA2 mutation carriers.
|
25830658 |
2015 |
Breast Carcinoma
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Following on these observations, we further assessed the link between the AURKA-HMMR-TPX2-TUBG1 functional module and risk of breast cancer in BRCA1 or BRCA2 mutation carriers.
|
25830658 |
2015 |
Malignant neoplasm of breast
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
A two SNP combination of rs10145182 in NIN and rs2134808 in the TUBG1 locus (P-interaction = 0.00001), suggested SNPs in mediators of microtubule nucleation from the centrosome contribute to breast cancer.
|
20508983 |
2011 |